2001
DOI: 10.1016/s0960-894x(00)00717-4
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and structure–activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human coronary artery smooth muscle cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 10 publications
0
8
0
Order By: Relevance
“…A mixture of 0.01 mol of 6-R-7-R 1 -1 H –benzo[d] [1,3] oxazine-2,4-diones 8b,c and 25 ml of aqueous ammonia solution (25%) was stirred for 1 h. The solid precipitate was removed by filtration, washed with an aqueous ammonia solution (5%) and crystallized from ethanol.…”
Section: Experimental Protocolsmentioning
confidence: 99%
See 1 more Smart Citation
“…A mixture of 0.01 mol of 6-R-7-R 1 -1 H –benzo[d] [1,3] oxazine-2,4-diones 8b,c and 25 ml of aqueous ammonia solution (25%) was stirred for 1 h. The solid precipitate was removed by filtration, washed with an aqueous ammonia solution (5%) and crystallized from ethanol.…”
Section: Experimental Protocolsmentioning
confidence: 99%
“…Some examples of biological activities of this class of compounds include activity against human coronary artery smooth muscle and endothelial cells [1], antifibrotic and antiinflammatory properties [2,3], inhibition of cornea pterygium progression and blood vessel development [4,5] and prevention and treatment of renal glomerular diseases [6]. In a previous paper from our laboratories [7], we reported the synthesis, antiproliferative activity and mechanism of action of a series of 2-{[2 E ]-3-phenylpropenamido}benzamides 1a–v (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Tranilast (Rizaben ® ) 2 is an antiallergic drug approved in 1982 for use in Japan and South Korea for bronchial asthma and was also investigated for use as an antiproliferative agent on drug-eluting stents. Its derivative ( E )-2-(3-(3,4-dime-thoxyphenyl)acrylamido)benzamide 3 [1] is another member of this class of compounds and is more potent than the lead compound, Tranilast (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%
“…Despite their wide range of biological activities, 1–6 a review of the literature revealed that no anticancer activity had been described for these compounds. This omission led us to explore the potential of this class of compounds as anticancer agents by synthesizing and screening for antileukemic activity a series of novel 2-cinnamamido, 2-(3-phenylpropiolamido) and 2-(3-phenylpropanamido)benzamides.…”
Section: Introductionmentioning
confidence: 99%